Literature DB >> 12201138

A Monte Carlo evaluation of the dosimetric characteristics of the Best Model 2301 125I brachytherapy source.

Keith T Sowards1, Ali S Meigooni.   

Abstract

Recently a new design of a 125I brachytherapy source was introduced for interstitial seed implants, particularly for prostate seed implants. This new source is the Best Model 2301 brachytherapy source. Due to the differences in source design and manufacturing process from one new source to the next, their dosimetric parameters should be determined according to the AAPM TG-43 guidelines. As per AAPM recommendation (Med. Phys. 25 (12) (1998) 2269), it is required to perform the seed dosimetry using at least one experimental study and one Monte Carlo simulation, preferably done by two separate investigators. Other investigators have experimentally determined the dosimetric parameters of this new source. In this project, the Monte Carlo simulated dosimetric parameters of the Best Model 2301 125I source have been provided. The results of this evaluation indicate the value of dose rate constant of 1.01 +/- 3% cGyh-1U-1 in liquid water, which is in good agreement with 1.02 +/- 8% cGyh-1U-1 reported by Nath and Yue, 2002. The anisotropy constant was found to be 0.98 in liquid water.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12201138     DOI: 10.1016/s0969-8043(02)00124-0

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  2 in total

1.  Reconstruction of brachytherapy seed positions and orientations from cone-beam CT x-ray projections via a novel iterative forward projection matching method.

Authors:  Damodar Pokhrel; Martin J Murphy; Dorin A Todor; Elisabeth Weiss; Jeffrey F Williamson
Journal:  Med Phys       Date:  2011-01       Impact factor: 4.071

2.  Comparison of TG-43 dosimetric parameters of brachytherapy sources obtained by three different versions of MCNP codes.

Authors:  Neda Zaker; Mehdi Zehtabian; Sedigheh Sina; Craig Koontz; Ali S Meigooni
Journal:  J Appl Clin Med Phys       Date:  2016-03-08       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.